These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 8653790)

  • 1. E2F-1 functions in mice to promote apoptosis and suppress proliferation.
    Field SJ; Tsai FY; Kuo F; Zubiaga AM; Kaelin WG; Livingston DM; Orkin SH; Greenberg ME
    Cell; 1996 May; 85(4):549-61. PubMed ID: 8653790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of specific E2F complexes by the v-mos oncogene.
    Afshari CA; Rhodes N; Paules RS; Mudryj M
    Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H; Iavarone A; Reeves SA
    Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos.
    Tsai KY; Hu Y; Macleod KF; Crowley D; Yamasaki L; Jacks T
    Mol Cell; 1998 Sep; 2(3):293-304. PubMed ID: 9774968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity.
    Murga M; Fernández-Capetillo O; Field SJ; Moreno B; Borlado LR; Fujiwara Y; Balomenos D; Vicario A; Carrera AC; Orkin SH; Greenberg ME; Zubiaga AM
    Immunity; 2001 Dec; 15(6):959-70. PubMed ID: 11754817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cell proliferation by the E2F transcription factors.
    Helin K
    Curr Opin Genet Dev; 1998 Feb; 8(1):28-35. PubMed ID: 9529602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection.
    Zhu JW; DeRyckere D; Li FX; Wan YY; DeGregori J
    Cell Growth Differ; 1999 Dec; 10(12):829-38. PubMed ID: 10616908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice.
    Bargou RC; Wagener C; Bommert K; Arnold W; Daniel PT; Mapara MY; Grinstein E; Royer HD; Dörken B
    J Exp Med; 1996 Mar; 183(3):1205-13. PubMed ID: 8642262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of E2F1 in mesangial cell proliferation in vitro.
    Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo.
    Agah R; Kirshenbaum LA; Abdellatif M; Truong LD; Chakraborty S; Michael LH; Schneider MD
    J Clin Invest; 1997 Dec; 100(11):2722-8. PubMed ID: 9389735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor induction and tissue atrophy in mice lacking E2F-1.
    Yamasaki L; Jacks T; Bronson R; Goillot E; Harlow E; Dyson NJ
    Cell; 1996 May; 85(4):537-48. PubMed ID: 8653789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint.
    Krek W; Xu G; Livingston DM
    Cell; 1995 Dec; 83(7):1149-58. PubMed ID: 8548802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity.
    Fabbrizio E; Le Cam L; Polanowska J; Kaczorek M; Lamb N; Brent R; Sardet C
    Oncogene; 1999 Jul; 18(30):4357-63. PubMed ID: 10439043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple members of the E2F transcription factor family are the products of oncogenes.
    Xu G; Livingston DM; Krek W
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1357-61. PubMed ID: 7877982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
    Hsiao KM; McMahon SL; Farnham PJ
    Genes Dev; 1994 Jul; 8(13):1526-37. PubMed ID: 7958837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the E2F-1/DP-1 transcription factor in murine development.
    Tevosian SG; Paulson KE; Bronson R; Yee AS
    Cell Growth Differ; 1996 Jan; 7(1):43-52. PubMed ID: 8788032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F-1-induced p53-independent apoptosis in transgenic mice.
    Holmberg C; Helin K; Sehested M; Karlström O
    Oncogene; 1998 Jul; 17(2):143-55. PubMed ID: 9674698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct roles for E2F proteins in cell growth control and apoptosis.
    DeGregori J; Leone G; Miron A; Jakoi L; Nevins JR
    Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7245-50. PubMed ID: 9207076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for E2F in DNA damage-induced entry of cells into S phase.
    Huang Y; Ishiko T; Nakada S; Utsugisawa T; Kato T; Yuan ZM
    Cancer Res; 1997 Sep; 57(17):3640-3. PubMed ID: 9288762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.